These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10594470)

  • 61. Assessment of type I error rates for the statistical sub-model in NONMEM.
    Wählby U; Bouw MR; Jonsson EN; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):251-69. PubMed ID: 12449498
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis.
    Wade JR; Kelman AW; Howie CA; Whiting B
    J Pharmacokinet Biopharm; 1993 Apr; 21(2):209-22. PubMed ID: 8229681
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Simple method for the estimation of absorption rate constant(ka) after oral administration.
    Mahmood I
    Am J Ther; 1998 Nov; 5(6):377-81. PubMed ID: 10099080
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetic studies in infants using minimal-risk study designs.
    Autmizguine J; Benjamin DK; Smith PB; Sampson M; Ovetchkine P; Cohen-Wolkowiez M; Watt KM
    Curr Clin Pharmacol; 2014; 9(4):350-8. PubMed ID: 24844642
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations.
    Ince I; Knibbe CA; Danhof M; de Wildt SN
    Clin Pharmacokinet; 2013 May; 52(5):333-45. PubMed ID: 23463352
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Population pharmacokinetic analysis during the first 2 years of life: an overview.
    Marsot A; Boulamery A; Bruguerolle B; Simon N
    Clin Pharmacokinet; 2012 Dec; 51(12):787-98. PubMed ID: 23179579
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.
    Johnson TN; Rostami-Hodjegan A; Tucker GT
    Clin Pharmacokinet; 2006; 45(9):931-56. PubMed ID: 16928154
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A comparison of the pharmacokinetics of two dosing regimens of cisapride and their effects on corrected QT interval in premature infants.
    Cools F; Benatar A; Bruneel E; Theyskens C; Bougatef A; Casteels A; Vandenplas Y
    Eur J Clin Pharmacol; 2003 May; 59(1):17-22. PubMed ID: 12682804
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and tolerability of cisapride in children.
    Vandenplas Y; Benatar A; Cools F; Arana A; Hegar B; Hauser B
    Paediatr Drugs; 2001; 3(8):559-73. PubMed ID: 11577921
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of cisapride on QTc interval in term neonates.
    Semama DS; Bernardini S; Louf S; Laurent-Atthalin B; Gouyon JB
    Arch Dis Child Fetal Neonatal Ed; 2001 Jan; 84(1):F44-6. PubMed ID: 11124924
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cisapride treatment for gastro-oesophageal reflux in children.
    Augood C; MacLennan S; Gilbert R; Logan S
    Cochrane Database Syst Rev; 2000; (3):CD002300. PubMed ID: 10908549
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Cisapride treatment for children with gastro-esophageal reflux].
    Kneepkens CM; Hoekstra JH; Vandenplas Y
    Ned Tijdschr Geneeskd; 1999 Oct; 143(42):2091-4. PubMed ID: 10560558
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease.
    Preechagoon Y; Charles B; Piotrovskij V; Donovan T; Van Peer A
    Br J Clin Pharmacol; 1999 Nov; 48(5):688-93. PubMed ID: 10594470
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny.
    Kearns GL; Robinson PK; Wilson JT; Wilson-Costello D; Knight GR; Ward RM; van den Anker JN;
    Clin Pharmacol Ther; 2003 Oct; 74(4):312-25. PubMed ID: 14534518
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Population pharmacokinetics of cisapride in neonates.
    Odoul F; Le Guellec C; Henrot A; Saliba E; Levron JC; Saux MC; Paintaud G; Autret-Leca E
    Eur J Clin Pharmacol; 2002 Nov; 58(8):507-13. PubMed ID: 12451427
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juice.
    Desta Z; Kivistö KT; Lilja JJ; Backman JT; Soukhova N; Neuvonen PJ; Flockhart DA
    Br J Clin Pharmacol; 2001 Oct; 52(4):399-407. PubMed ID: 11678783
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.